Advanced search
Publication Cover
Expert Review of Molecular Diagnostics Volume 19, 2019 - Issue 6
Submit an article Journal homepage
290
Views
12
CrossRef citations to date
0
Altmetric
Review

Research progress and clinical application of predictive biomarker for immune checkpoint inhibitors

Ke MaDepartment of Pharmacology, School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang, ChinaView further author information
,
Qingqing JinDepartment of Pharmacology, School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang, ChinaView further author information
,
Miao WangDepartment of Pharmacology, School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang, ChinaView further author information
,
Xin LiDepartment of Pharmacology, School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang, ChinaView further author information
&
Yuyang ZhangDepartment of Pharmacology, School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang, ChinaCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-7759-1211View further author information
ORCID Icon
Pages 517-529 | Received 14 Feb 2019, Accepted 08 May 2019, Published online: 22 May 2019

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Hongxia Cheng, Sikai Wang, Aidan Huang, Jing Ma, Dongmei Gao, Miaomiao Li, Huaping Chen & Kun Guo. (2023) HSF1 is involved in immunotherapeutic response through regulating APOJ/STAT3-mediated PD-L1 expression in hepatocellular carcinoma. Cancer Biology & Therapy 24:1, pages 1-9.
Read now
Wei Liu, Lei Zhang, Zhiming Xiu, Jian Guo, Liye Wang, Yue Zhou, Yang Jiao, Meiyan Sun & Jianhui Cai. (2020) Combination of Immune Checkpoint Inhibitors with Chemotherapy in Lung Cancer. OncoTargets and Therapy 13, pages 7229-7241.
Read now

Articles from other publishers (10)

Seyed Mohammadmahdi Meybodi, Bahareh Farasati Far, Ali Pourmolaei, Farid Baradarbarjastehbaf, Maryam Safaei, Niloufar Mohammadkhani & Ali Akbar Samadani. (2023) Immune checkpoint inhibitors promising role in cancer therapy: clinical evidence and immune-related adverse events. Medical Oncology 40:8.
Crossref
Yu Xu, Ke Ma, Fan Zhang, Minting Ma, Lei Hong, Jing Wang, Suping Li, Panpan Sun, Junyan Wang & Suju Wei. (2023) Association between baseline C‑reactive protein level and survival outcomes for cancer patients treated with immunotherapy: A meta‑analysis. Experimental and Therapeutic Medicine 26:2.
Crossref
Min Li, Rongrong Wu, Dongyi Zhu, Le Wang, Shinan Liu, Ruolan Wang, Chaowen Deng, Shenglin Zhang, Min Chen, Ruojin Lu, Hongxing Zhu, Mengting Mo & Zhuang Luo. (2023) Nucleophosmin promotes lung adenocarcinoma cell proliferation, migration and invasion by activating the EGFR/MAPK signaling pathway. Oncology Reports 49:6.
Crossref
Xuelin Yun, Hailong Qin, Bin Du, Yu Peng, Yuling Liu, Yao Yuan, Jie Meng & Bixian Yang. (2023) Inhibitory effect and mechanism of hirsuteine on NCI‑H1299 lung cancer cell lines. Oncology Letters 25:5.
Crossref
Kyoichi Kaira, Hisao Imai, Tomonori Kawasaki, Kousuke Hashimoto, Yu Miura, Ayako Shiono, Ou Yamaguchi, Atsuto Mouri, Kunihiko Kobayashi, Masanori Yasuda & Hiroshi Kagamu. (2022) Potential of VEGFR2 expression as a predictive marker of PD‑1 blockade in patients with advanced NSCLC. Oncology Reports 48:6.
Crossref
Maria Davern, Noel E. Donlon, Fiona O’ Connell, Andrew D. Sheppard, Conall Hayes, Ross King, Hugo Temperley, Christine Butler, Anshul Bhardwaj, Jenny Moore, Dara Bracken-Clarke, Claire Donohoe, Narayanasamy Ravi, John V. Reynolds, Stephen G. Maher, Melissa J. Conroy & Joanne Lysaght. (2022) Cooperation between chemotherapy and immune checkpoint blockade to enhance anti-tumour T cell immunity in oesophageal adenocarcinoma. Translational Oncology 20, pages 101406.
Crossref
Zekhethelo A. Mkhwanazi, Snenhlanhla A. Mfusi & Bongani B. Nkambule. (2022) Prognostic value of CD20 antigen mediated immune checkpoint inhibition in patients with acute or chronic lymphocytic leukemia. Medicine 101:7, pages e28868.
Crossref
Maria Davern & Joanne Lysaght. (2020) Cooperation between chemotherapy and immunotherapy in gastroesophageal cancers. Cancer Letters 495, pages 89-99.
Crossref
Piera Federico, Angelica Petrillo, Pasqualina Giordano, Davide Bosso, Antonietta Fabbrocini, Margaret Ottaviano, Mario Rosanova, Antonia Silvestri, Andrea Tufo, Antonio Cozzolino & Bruno Daniele. (2020) Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Status and Novel Perspectives. Cancers 12:10, pages 3025.
Crossref
Luochengling Xiang, Xiao Fu, Xiao Wang, Wenyuan Li, Xiaoqiang Zheng, Kejun Nan & Tao Tian. (2020) A Potential Biomarker of Combination of Tumor Mutation Burden and Copy Number Alteration for Efficacy of Immunotherapy in KRAS-Mutant Advanced Lung Adenocarcinoma. Frontiers in Oncology 10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.